Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.
Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA. Yeung AR, et al. Among authors: bruner dw. J Clin Oncol. 2020 May 20;38(15):1685-1692. doi: 10.1200/JCO.19.02381. Epub 2020 Feb 19. J Clin Oncol. 2020. PMID: 32073955 Free PMC article. Clinical Trial.
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G; National Cancer Institute. Bruner DW, et al. J Clin Oncol. 2007 Nov 10;25(32):5051-7. doi: 10.1200/JCO.2007.11.3324. J Clin Oncol. 2007. PMID: 17991920 Free PMC article. Review.
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward.
Lipscomb J, Reeve BB, Clauser SB, Abrams JS, Bruner DW, Burke LB, Denicoff AM, Ganz PA, Gondek K, Minasian LM, O'Mara AM, Revicki DA, Rock EP, Rowland JH, Sgambati M, Trimble EL. Lipscomb J, et al. Among authors: bruner dw. J Clin Oncol. 2007 Nov 10;25(32):5133-40. doi: 10.1200/JCO.2007.12.4644. J Clin Oncol. 2007. PMID: 17991933 Review.
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer.
Shah A, Efstathiou JA, Paly JJ, Halpern SD, Bruner DW, Christodouleas JP, Coen JJ, Deville C Jr, Vapiwala N, Shipley WU, Zietman AL, Hahn SM, Bekelman JE. Shah A, et al. Among authors: bruner dw. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e13-9. doi: 10.1016/j.ijrobp.2011.11.072. Epub 2012 Feb 28. Int J Radiat Oncol Biol Phys. 2012. PMID: 22381899
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. Hoffman KE, et al. Among authors: bruner dw. Qual Life Res. 2014 Aug;23(6):1841-58. doi: 10.1007/s11136-014-0628-5. Epub 2014 Feb 4. Qual Life Res. 2014. PMID: 24492945 Free PMC article. Clinical Trial.
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Bruner DW, Hunt D, Michalski JM, Bosch WR, Galvin JM, Amin M, Xiao C, Bahary JP, Patel M, Chafe S, Rodrigues G, Lau H, Duclos M, Baikadi M, Deshmukh S, Sandler HM. Bruner DW, et al. Cancer. 2015 Jul 15;121(14):2422-30. doi: 10.1002/cncr.29362. Epub 2015 Apr 2. Cancer. 2015. PMID: 25847819 Free PMC article. Clinical Trial.
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, Chen Y, Koontz BF, Paulus R, Sandler HM. Lee WR, et al. Among authors: bruner dw. J Clin Oncol. 2016 Jul 10;34(20):2325-32. doi: 10.1200/JCO.2016.67.0448. Epub 2016 Apr 4. J Clin Oncol. 2016. PMID: 27044935 Free PMC article. Clinical Trial.
232 results